Quarterly Result28 May 2026, 08:30 pm
CLINITECH LAB Board approves FY26 Audited Financial Results
AI Summary
CLINITECH LABORATORY LIMITED's Board of Directors met on May 28, 2026, to approve the Audited Standalone & Consolidated Financial Results for the half year and financial year ended March 31, 2026. The Board also took note of the Internal Audit Report for the half year ended March 31, 2026, and reviewed related party transactions for FY 2025-26, approving estimated transactions for FY 2026-27. The Statutory Auditors, M/s Kale Malde & Co., issued an "unmodified opinion" on the financial statements. The company also enclosed a certificate regarding the utilization of issue proceeds.
Key Highlights
- Board approved audited Standalone & Consolidated Financial Results for FY2026.
- Statutory Auditors issued an unmodified opinion on the financial statements.
- Related party transactions for FY2026 were noted and FY2027 estimates approved.
- Internal Audit Report for the second half of FY2026 was reviewed.
Price Impact
More from CTLLAB